Pure Global

ANTIBODY FOR CELIAC DISEASE - ANVISA Registration 10338930273

Access comprehensive regulatory information for ANTIBODY FOR CELIAC DISEASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10338930273 and manufactured by EUROIMMUN AG. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, INOVA DIAGNOSTICS, INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10338930273
Registration Details
ANVISA Registration Number: 10338930273
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

IFI: Doença Celíaca Screen (LM) EUROPattern (IgG)
Risk Class II

Registration Details

10338930273

25351021118202236

93741726000166

Company Information

EUROIMMUN AG
Germany
PT: ALEMANHA

Dates and Status

Jan 20, 2022

VIGENTE

09/18/2025 19:00:01